MYRIAD GENETICS, INC. Operating Leases, Income Statement, Sublease Revenue
MYRIAD GENETICS, INC. (MYGN) reported Operating Leases, Income Statement, Sublease Revenue of $2.62 million for the 12-month period ending 2012-06-30, per its 10-K filed 2012-08-15.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue · last filed 2012-08-15
- MYRIAD GENETICS, INC. operating leases, income statement, sublease revenue for fiscal 2012 was $2.62M, a 0.04% decline from fiscal 2011.
- MYRIAD GENETICS, INC. operating leases, income statement, sublease revenue for fiscal 2011 was $2.62M, a 9.40% decline from fiscal 2010.
- MYRIAD GENETICS, INC. operating leases, income statement, sublease revenue for fiscal 2010 was $2.90M.
| Period end | Operating Leases, Income Statement, Sublease Revenue 12 month |
|---|---|
| 2012-06-30 | $2.62M 10-K · filed 2012-08-15 |
| 2011-06-30 | $2.62M 10-K · filed 2012-08-15 |
| 2010-06-30 | $2.90M 10-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |